{"title":"儿童和青少年精神病学中左旋丙嗪（又称甲氨蝶呤，又称诺齐南）的使用","authors":"J. Lambe","doi":"10.12970/2310-8231.2021.09.07","DOIUrl":null,"url":null,"abstract":"Levomepromazine is rarely used in child and adolescent psychiatry. Four cases are described where extreme behavioural disturbance responded favourably and promptly to oral prescription. Two additional cases are described where ceasing levomepromazine led to early signs of what was probably tardive dyskinesia, resolving completely.","PeriodicalId":91283,"journal":{"name":"International journal of clinical psychiatry and mental health","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Levomepromazine, a.k.a. Methotrimeprazine, a.k.a. Nozinan, in Child and Adolescent Psychiatry\",\"authors\":\"J. Lambe\",\"doi\":\"10.12970/2310-8231.2021.09.07\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Levomepromazine is rarely used in child and adolescent psychiatry. Four cases are described where extreme behavioural disturbance responded favourably and promptly to oral prescription. Two additional cases are described where ceasing levomepromazine led to early signs of what was probably tardive dyskinesia, resolving completely.\",\"PeriodicalId\":91283,\"journal\":{\"name\":\"International journal of clinical psychiatry and mental health\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of clinical psychiatry and mental health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12970/2310-8231.2021.09.07\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical psychiatry and mental health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12970/2310-8231.2021.09.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Use of Levomepromazine, a.k.a. Methotrimeprazine, a.k.a. Nozinan, in Child and Adolescent Psychiatry
Levomepromazine is rarely used in child and adolescent psychiatry. Four cases are described where extreme behavioural disturbance responded favourably and promptly to oral prescription. Two additional cases are described where ceasing levomepromazine led to early signs of what was probably tardive dyskinesia, resolving completely.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
